While lung cancer rates have decreased by 43% in men, they have risen by 79% in women. Broader screening guidelines and recognizing early symptoms can help address the changing face of lung cancer.
Labeling medical test results as 'normal' or 'abnormal' helps clinicians make quick judgments when diagnosing patients. But this binary approach to interpreting tests can lead to fatal errors.